This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Bacterial Infections


  • Researchers Discover Human Immune System Has Emergency Back-up Plan
    New research by scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences reveals that the immune system has an effective backup plan to protect the body from infection when the "master regulator" of ...More
    December 20, 2010 Posted in News
  • ContraFect, Rockefeller University to Commercialize Patents for Lysin Enzymes
    ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug-resistant bacteria, announced that it has licensed from the Rockefeller University a suite of eight patents to lysin (antibacterial) enzymes. Lysins are enzymes ...More
    November 19, 2010 Posted in News
  • Mechanism Allows Host Organism to Outsmart an Invading Bacterium
    New research reveals a clever strategy that enables a host organism to outsmart an invading bacterium by counteracting its efforts to suppress the innate immune response. The study, published in the Nov. 24 issue of the journal Immunity, describes a mechanism by which an ...More
    November 18, 2010 Posted in News
  • Vitamin C: A Potential Life-Saving Treatment for Sepsis
    Physicians caring for patients with sepsis may soon have a new safe and cost-effective treatment for this life-threatening illness. Research led by Dr. Karel Tyml and his colleagues at the University of Western Ontario and Lawson Health Research Institute have found that ...More
    November 18, 2010 Posted in News
  • Cholesterol-Lowering Statins Boost Bacteria-Killing Cells
    Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis. A new explanation for these findings ...More
    November 17, 2010 Posted in News
  • FDA Offers Tips for Fighting Off Winter Illnesses
    In much of the Northern Hemisphere, this is prime time for colds, influenza (flu), and other respiratory illnesses. While contagious viruses are active year-round, fall and winter are when we're all most vulnerable to them. This is due in large part to people spending more ...More
    November 3, 2010 Posted in News
  • Extra ED Surveillance Doesn't Benefit Conventional Surveillance for Meningococcal Infection
    Researchers in New South Wales, Australia report in the latest issue of BMC Infectious Diseases that use of an emergency department (ED) surveillance system to augment conventional surveillance of meningococcal infection did not demonstrate a benefit. O'Toole and colleagues ...More
    November 3, 2010 Posted in News
  • Study Re-Examines Bacterial Vaccine Studies Conducted During 1918 Influenza Pandemic
    Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be important in modern pandemics as well, according to a new article in the Journal of Infectious Diseases ...More
    November 2, 2010 Posted in News
  • Protein Preserves Delicate Balance Between Immune Response and Host
    White blood cells called neutrophils are part of the body's first line of defense against bacterial infection. Neutrophils are recruited from the bloodstream to infected tissues where they release powerful chemicals that kill bacteria and amplify the immune response. These ...More
    November 1, 2010 Posted in News
  • FDA Approves Teflaro for Bacterial Infections
    The Food and Drug Administration (FDA) announces it has approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including ...More
    November 1, 2010 Posted in News